Diatron (US) Reagent Kit DRI Drugs of Abuse Benzodiazepine (BZO) For Clinical Chemistry Analyzers 500 mL - M-1105592-4021 | Box of 1

Packaging *

Diatron (US)

Reagent

In Stock

M-1105592-4021

-
+
$1,668.99

Item is Non - Returnable

Delivery - 7-10 Days, Ship Directly from Manufacturer

  • The DRI® Benzodiazepine Assay is a homogeneous enzyme immunoassay intended for the qualitative and/or semi-quantitative determination of the presence of benzodiazepines and their metabolites in human urine at a cutoff concentration of 200 ng/mL
  • The assay is intended to be used in laboratories and provides a rapid analytical screening procedure to detect benzodiazepines in human urine

  • Item Id 1105592
    MF ID DT0040
    Brand DRI®
    Manufacturer Diatron (US)
    Application Reagent Kit
    For Use With For Clinical Chemistry Analyzers
    Form Ready-to-use Liquid
    Sample Type Urine Sample
    Storage Requirements Requires Refrigeration
    Test Name Benzodiazepine (BZO)
    Test Type Drugs of Abuse
    Type Homogenous Enzyme Immunoassay (HEIA)
    UNSPSC Code 41116004
    Volume 500 mL

    Recently Viewed Products

    FDA Disclaimer: "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."